相关实验视频

Updated: Aug 8, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

超越传统光线:用于癌症治疗的NIR-II光激活光敏剂

Sa Wang¹, Chuang Zhang¹, Fang Fang¹

¹Key Laboratory of Molecular Medicine and Biotherapy, School of Life Sciences, Beijing Institute of Technology, Beijing 100081, P. R. China. jfzhang@bit.edu.cn.

Journal of materials chemistry. B

|July 31, 2023

概括

新的光敏感剂正在开发用于近红外II (NIR-II) 光,改善光动力学疗法 (PDT) 进行更深层次的癌症治疗. 本综述强调了NIR-II光敏剂在增强癌症护理方面的进展和挑战.

科学领域:

生物医学工程生物医学工程
材料科学材料科学材料科学
在瘤学瘤学.

背景情况:

光动力疗法 (PDT) 是一种有前途的非侵入性癌症治疗方法.
传统的PDT面临的局限性是由于短波长光的组织透能力较差.
近红外II (NIR-II) 光提供更深的透和更好的组织耐受性,以提高治疗效果.

研究的目的:

审查癌症PDT的NIR-II光敏化剂的最新进展.
讨论NIR-II光敏剂在临床应用中的挑战和未来前景.

主要方法:

对最近关于NIR-II光敏剂的研究进行了全面的文献综述.
对各种NIR-II光敏化剂的性能和性能进行分析.
讨论临床翻译挑战和未来的研究方向.

主要成果:

在开发新型NIR-II光敏剂方面取得了重大进展.
激发NIR-II可使光线透得更深,提高了PDT对各种癌症的有效性.
目前的研究重点是为临床转化优化光敏剂设计.

结论:

NIR-II光敏剂具有革命性癌症PDT的巨大潜力.
克服当前的挑战对于临床采用NIR-II PDT至关重要.
跨学科的研究对于推进NIR-II光敏剂的开发和应用至关重要.

更多相关视频

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

A Bright NIR-II Fluorescence Probe for Vascular and Tumor Imaging

Published on: March 17, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.